We describe sequence analysis of the mitochondrial DNA of five Hungarian patients diagnosed with probable LHON, who do not carry any of the three primary point mutations. We report three novel mutations, one of which might have a pathogenic rol

Horvath, J.

Horvath, R.

Johns, D.

Karcagi, V.

Komoly, S.

RERO DOC Digital Library

SHORT REPORTSequence analysis of Hungarian LHON patients not carrying the commonprimary mutationsJ. Horvath1*, R. Horvath2, V. Karcagi3, S. Komoly4 and D. R. Johns51Department of Neurology and Neurosciences, Geneva University Hospital, Switzerland;2Metabolic Disease Center Munich-Schwabing, Muenchen, Germany; 3Department ofApplied Biochemistry, Fodor Jozsef National Center for Public Health, Budapest, Hungary;4Department of Neurology, Jahn Ferenc Hospital, Budapest, Hungary; 5Department ofNeurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA*Correspondence: Department of Neurology and Neurosciences, Geneva UniversityHospital, Rue Micheli-du-Crest 24, 1211 Geneva, Switzerland.E-mail: Judit.Horvath@hcuge.chSummary: We describe sequence analysis of the mitochondrial DNA of ¢veHungarian patients diagnosed with probable LHON, who do not carry anyof the three primary point mutations. We report three novel mutations, oneof which might have a pathogenic role.Leber hereditary optic neuropathy (LHON) is a maternally inherited disease charac-terized by a subacute, sequential, bilateral loss of central vision. The vast majority ofLHON cases are associated with one of the three primary point mutations atnucleotide positions np11778, np3460 and npl4484 of the mitochondrial DNA(mtDNA).In this report, we describe the sequencing analysis of the mtDNA of ¢veHungarian patients (H1^H5) who were diagnosed with probable LHON but weretested negative for the three primary point mutations. H1 and H2 are siblings whilethe three other patients have no family history.We have sequenced all the complex I genes of the mtDNA of patients H1, H3, H4and H5. For patients H1 and H5 we extended our sequencing analysis to thecytochrome-c oxidase (COX) I, COX II, COX III, and the cytochrome b (Cytb)genes (Anderson et al 1981).The DNAs had been isolated from total blood using a standard protocol of saltprecipitation and were ampli¢ed using standard PCR conditions. The sequencingwas performed on a polyacrylamide gel using an ABI 377 automated sequencer.For the identi¢ed novel mutation at np10237 we created a restriction digest testwith AseI.We found that patient H3 carries a C-to-A transition at npl3735 of the ND5 geneleading to a replacement of a nonconserved leucine by an isoleucine (Leu467Ile).Sequencing the complex I genes of patient H4 revealed a few silent mutations only.Patient H5 was found to carry the sequence variations characteristic of the Europeanhaplogroup J. In addition, he carries a homoplasmic C-to-T transition at np10192that results in a replacement of a not very conserved serine by a phenylalanineJ. Inherit. Metab. Dis. 25 (2002) 323^324# SSIEM and Kluwer Academic Publishers. Printed in the Netherlands.323residue at codon 45 of the ND3 gene (Ser45Phe) (Fearnley and Walker 1992). Thepathogenic role of these mutations in LHON does not seem to be likely (Huoponenet al 1993).Our most remarkable ¢nding is a homoplasmic T-to-C transition at np10237 ofthe ND3 gene of patients H1 and H2 resulting in a substitution of an isoleucinewith a threonine residue (Ile59Thr). It occurs in a very conserved region of theND3 gene, in a potential membran-spanning a-helix. The isoleucine at this positionis highly conserved: other species carry lle, Leu or Val at this position and theseare all amino acids with a hydrophobic side-chain (Fearnley and Walker 1992).Threonine, however, has an aliphatic hydroxyl side-chain. The mutation is also pre-sent in homoplasmic form in the mother and maternal aunt of patients H1 andH2 but was not found in the 85 control DNA samples from the same ethnicbackground, and was also absent in a control group of 100 DNA samples studiedrecently by R. Horvath (personal communication). Apart from the mutationl0237T>C, patients H1 and H2 carry some previously identi¢ed polymorphisms thatare not suspected to have a pathogenic role. Since we have no knowledge of othera¡ected family members we cannot rule out the possibility of a recessive optic atro-phy in this case. Still the mutation 10237T>C deserves attention. Biochemicalstudies and further data about its occurrence in LHON and control populationscan determine its role in the pathogenesis of LHON.REFERENCESAnderson S, Bankier AT, Barrell BG, et al (1981) Sequence and organisation of the humanmitochondrial genome. Nature 290: 457^465.Fearnley IM, Walker JE (1992) Conservation of sequences of subunits of mitochondrialcomplex I and their relationship with other proteins. Biochim Biophys Acta 1140: 105^134.Huoponen K, Lamminen T, Juvonen V, Aula P, Nikoskelainen E, Savontaus ML (1993) Thespectrum of mitochondrial DNA mutations in families with Leber hereditary opticneuroretinopathy. Hum Genet 92: 379^384.324 Short ReportJ. Inherit. Metab. Dis. 25 (2002)

Sequence analysis of Hungarian LHON patients not carrying the common primary mutations

http://doc.rero.ch/record/315793/files/10545_2004_Article_5095801.pdf

Sequence analysis of Hungarian LHON patients not carrying the common primary mutations

Abstract

Similar works

Full text

Available Versions

RERO DOC Digital Library